September 9, 2026 Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study Weight-loss drug users who regained weight had 4.2 times higher odds of suicidal ideation, according to a study analyzing data from over 27,000 adults.
September 8, 2026 Drug developed for lung disease may slow biological aging in surprising ‘bonus’ Rentosertib, an AI-discovered drug for idiopathic pulmonary fibrosis, made patients appear three to four years biologically younger in a clinical trial.
September 7, 2026 Supporters of Alabama school bus driver charged in deadly accident say she suffered from 'medical crisis' Theresa McCloud faces vehicular homicide charges after a fatal Auburn school bus crash, but supporters claim a sudden blood sugar drop caused the accident.
September 5, 2026 ‘Black widow’ allegedly attempted to murder romantic partner, 69, she met online Samantha Adams allegedly slipped benzodiazepines into a drink she gave the 69-year-old victim she met on a dating app, Polk County sheriff says.
September 4, 2026 Common cholesterol drug linked to lower dementia risk when started early A massive study found that starting statins within a year of a type 2 diabetes diagnosis was linked to a 15% lower risk of dementia over a decade.
September 2, 2026 Women who start common hormone therapy in their 50s may have 23% lower dementia risk Hormone replacement therapy started between ages 46 and 56 was tied to lower Alzheimer's and dementia risk, a major new UK Biobank study suggests.
September 2, 2026 New weight-loss compound melts fat without curbing appetite — and preserves muscle University of California, Berkeley scientists found TOFA boosted energy expenditure in obese mice without the lean muscle loss tied to semaglutide.
August 28, 2026 Common vaccine linked to 24% lower dementia risk in older adults A Brown University study found Shingrix reduced dementia risk by 24% over four years, building on prior research linking the shingles vaccine to brain health.
August 26, 2026 FDA approves once-daily pill for deadly cancer after patients' survival rates nearly double Revolution Medicines' Rasonque targets the RAS protein driving 95% of pancreatic adenocarcinoma cases, offering a critical option after chemotherapy fails.
August 25, 2026 Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.